Johnson & Johnson (NYSE: JNJ) is favored by money managers for its stability in an economic slowdown. With products like toothpaste and medicine, J&J can thrive regardless of the economy. However, some believe other AI stocks offer greater upside potential and less downside risk compared to JNJ.

JNJ develops and sells healthcare products, including pharmaceuticals and medical technologies. The company offers treatments in various areas such as immunology, oncology, and cardiovascular care. Additionally, J&J provides surgical systems, orthopaedic solutions, cardiovascular devices, and vision care products.

While JNJ is viewed as a solid investment, some argue that certain AI stocks present better opportunities. For those seeking an undervalued AI stock with potential benefits from Trump-era tariffs, consider exploring other options. Check out our report on the best short-term AI stock for more information.

Read more at Yahoo Finance: “J&J Deserves to Be Going Higher, But Not at This Speed, Not at This Pace”